title: Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Gonzalez-Gay
authors.forename: Carlos
authors.initials: C
authors.lastname: Gonzalez-Juanatey
authors.forename: Jose A
authors.initials: JA
authors.lastname: Miranda-Filloy
authors.forename: Javier
authors.initials: J
authors.lastname: Martin
authors.forename: Maria T
authors.initials: MT
authors.lastname: Garcia-Unzueta
authors.forename: Javier
authors.initials: J
authors.lastname: Llorca
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001823:Body Composition / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents